Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway

Cancer Science

Volumn 107, Issue 1, 2016, Pages 18-27

  Xue, Mei ^a   Pang, Huan ^a   Li, Xu ^a   Li, Huijin ^a   Pan, Jingjing ^a   Chen, Wei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Bladder cancer; Epithelial to mesenchymal transition; Hsa miR 145; Long non coding RNA; UCA1

Indexed keywords

ACTIN BINDING PROTEIN; FASCIN HOMOLOGUE 1 PROTEIN; LONG NON CODING RNA UROTHELIAL CANCER ASSOCIATED 1; LONG UNTRANSLATED RNA; MICRORNA 145; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; UNCLASSIFIED DRUG; CARRIER PROTEIN; FSCN1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; MICRORNA; MIRN145 MICRORNA, HUMAN; REPRESSOR PROTEIN; UCA1 RNA, HUMAN; ZEB1 PROTEIN, HUMAN; ZEB2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CELL; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MIDDLE AGED; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; BIOSYNTHESIS; BLADDER TUMOR; EPITHELIAL MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; TUMOR INVASION; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CARCINOMA, TRANSITIONAL CELL; CARRIER PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICROFILAMENT PROTEINS; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; URINARY BLADDER NEOPLASMS; ZINC FINGER E-BOX-BINDING HOMEOBOX 1;

EID: 84956588568     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12844     Document Type: Article

References (45)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5-29.
2. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011; 147: 275-92.
3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74.
4. Guo F, Parker KB, Yang D et al. Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions. J Hematol Oncol 2014; 7: 19.
5. Hu X, Feng Y, Zhang D et al. A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell 2014; 26: 344-57.
6. Zhang Z, Zhu Z, Watabe K et al. Negative regulation of lncRNA GAS5 by miR-21. Cell Death Differ 2013; 20: 1558-68.
7. Hou P, Zhao Y, Li Z et al. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis 2014; 5: e1287.
8. Yuan JH, Yang F, Wang F et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 2014; 25: 666-81.
9. Han Y, Liu Y, Zhang H et al. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long noncoding RNA MALAT1. FEBS Lett 2013; 587: 3875-82.
10. Wang XS, Zhang Z, Wang HC et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res 2006; 12: 4851-8.
11. Wang F, Li X, Xie X, Zhao L, Chen W. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett 2008; 582: 1919-27.
12. Fan Y, Shen B, Tan M et al. Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J 2014; 281: 1750-8.
13. Li Z, Li X, Wu S, Xue M, Chen W. Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/microRNA143 pathway. Cancer Sci 2014; 105: 951-5.
14. Fang Z, Wu L, Wang L, Yang Y, Meng Y, Yang H. Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol 2014; 117: 89-95.
15. Tian Y, Zhang X, Hao Y, Fang Z, He Y. Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma. Melanoma Res 2014; 24: 335-41.
16. Li JY, Ma X, Zhang CB. Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 2014; 7: 7938-44.
17. Zheng Q, Wu F, Dai WY et al. Aberrant expression of UCA1 in gastric cancer and its clinical significance. Clin Transl Oncol 2015; 17: 640-6.
18. Wang F, Zhou J, Xie X et al. Involvement of SRPK1 in cisplatin resistance related to long non-coding RNA UCA1 in human ovarian cancer cells. Neoplasma 2015; 62: 432-8.
19. Wang F, Ying HQ, He BS et al. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget 2015; 6: 7899-917.
20. Chiyomaru T, Enokida H, Tatarano S et al. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 2010; 102: 883-91.
21. Cioce M, Ganci F, Canu V et al. Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma. Oncogene 2014; 33: 5319-31.
22. Hu J, Qiu M, Jiang F et al. MiR-145 regulates cancer stem-like properties and epithelial-to-mesenchymal transition in lung adenocarcinoma-initiating cells. Tumour Biol 2014; 35: 8953-61.
23. Ren D, Wang M, Guo W et al. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells. Cell Tissue Res 2014; 358: 763-78.
24. Gupta RA, Shah N, Wang KC et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-6.
25. Prensner JR, Iyer MK, Sahu A et al. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet 2013; 45: 1392-8.
26. Fan Y, Shen B, Tan M et al. TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Cancer Res 2014; 20: 1531-41.
27. Han Y, Ye J, Wu D et al. LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition. BMC Cancer 2014; 14: 932.
28. Huang J, Zhou N, Watabe K et al. Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis 2014; 5: e1008.
29. Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal 2014; 7: e8.
30. Chivukula RR, Shi G, Acharya A et al. An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration. Cell 2014; 157: 1104-16.
31. Yoshino H, Enokida H, Itesako T et al. Tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma. Cancer Sci 2013; 104: 1567-74.
32. Villadsen SB, Bramsen JB, Ostenfeld MS et al. The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer. Br J Cancer 2012; 106: 366-74.
33. Yoshino H, Seki N, Itesako T, Chiyomaru T, Nakagawa M, Enokida H. Aberrant expression of microRNAs in bladder cancer. Nat Rev Urol 2013; 10: 396-404.
34. Sachdeva M, Zhu S, Wu F et al. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 2009; 106: 3207-12.
35. Zaman MS, Chen Y, Deng G et al. The functional significance of microRNA-145 in prostate cancer. Br J Cancer 2010; 103: 256-64.
36. Kano M, Seki N, Kikkawa N et al. miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 2010; 127: 2804-14.
37. Gao P, Xing AY, Zhou GY et al. The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer. Oncogene 2013; 32: 491-501.
38. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta stone of a hidden RNA language? Cell 2011; 146: 353-8.
39. Cesana M, Cacchiarelli D, Legnini I et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011; 147: 358-69.
40. Kallen AN, Zhou XB, Xu J et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell 2013; 52: 101-12.
41. Wang Y, Xu Z, Jiang J et al. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell 2013; 25: 69-80.
42. Zhou X, Gao Q, Wang J, Zhang X, Liu K, Duan Z. Linc-RNA-RoR acts as a "sponge" against mediation of the differentiation of endometrial cancer stem cells by microRNA-145. Gynecol Oncol 2014; 133: 333-9.
43. Takahashi K, Yan IK, Haga H, Patel T. Modulation of hypoxia-signaling pathways by extracellular linc-RoR. J Cell Sci 2014; 127: 1585-94.
44. Xue M, Li X, Li Z, Chen W. Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1alpha-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion. Tumour Biol 2014; 35: 6901-12.
45. Wang T, Yuan J, Feng N et al. Hsa-miR-1 downregulates long non-coding RNA urothelial cancer associated 1 in bladder cancer. Tumour Biol 2014; 35: 10075-84.